Eduardo Bruno Martins
SVP, Liver and Infectious Dise, Eiger BioPharmaceuticals, Inc.
Companies
- Sagimet Biosciences Inc.Chief Medical Officer Jul 20, 2023 to now1
- Sagimet Biosciences Inc.Board member Jul 13, 2023 to Jul 13, 20232
- Eiger BioPharmaceuticals, Inc.SVP, Liver and Infectious Dise Mar 25, 2016 to Mar 14, 20173
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Sagimet Biosciences Inc. SGMT147,296 shares4$1.3M at $8.82Feb 19, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 19, 2026Granted 44,000 shares of Sagimet Biosciences Inc.4
- Feb 10, 2026Sold 3,640 shares at $5.36 of Sagimet Biosciences Inc.5
- Jul 21, 2025Sold 8,277 shares at $9.13 of Sagimet Biosciences Inc.6
- Feb 6, 2025Granted 34,000 shares of Sagimet Biosciences Inc.7
- Jul 19, 2024Sold 8,357 shares at $3.10 of Sagimet Biosciences Inc.8
- Nov 17, 2023Granted 89,570 shares of Sagimet Biosciences Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Feb 12, 2026
- 6SEC EDGARForm 4 filed Jul 23, 2025
- 7SEC EDGARForm 4 filed Feb 7, 2025
- 8SEC EDGARForm 4 filed Jul 23, 2024
- 9SEC EDGARForm 4 filed Nov 21, 2023